Correlation Between Akari Therapeutics and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Aquestive Therapeutics, you can compare the effects of market volatilities on Akari Therapeutics and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Aquestive Therapeutics.
Diversification Opportunities for Akari Therapeutics and Aquestive Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Akari and Aquestive is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Aquestive Therapeutics
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Aquestive Therapeutics. In addition to that, Akari Therapeutics is 2.4 times more volatile than Aquestive Therapeutics. It trades about -0.26 of its total potential returns per unit of risk. Aquestive Therapeutics is currently generating about -0.1 per unit of volatility. If you would invest 549.00 in Aquestive Therapeutics on August 29, 2024 and sell it today you would lose (61.00) from holding Aquestive Therapeutics or give up 11.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Aquestive Therapeutics
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Aquestive Therapeutics |
Akari Therapeutics and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Aquestive Therapeutics
The main advantage of trading using opposite Akari Therapeutics and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
| Aquestive Therapeutics vs. Capricor Therapeutics | Aquestive Therapeutics vs. Soleno Therapeutics | Aquestive Therapeutics vs. Bio Path Holdings | Aquestive Therapeutics vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |